Literature DB >> 9016594

Two step synthesis of (-) strong-stop DNA by avian and murine reverse transcriptases in vitro.

C Isel1, C Ehresmann, G Keith, B Ehresmann, R Marquet.   

Abstract

Retroviral reverses transcriptases (RTs) are RNA- and DNA-dependent DNA polymerases that use a tRNA bound at the so-called primer binding site (PBS) located near the 5'end of the genomic RNA as primer. Thus, RTs must be able to accommodate both RNA and DNA in the primer strand. To test whether the natural primer confers some advantages to the priming process, we compared initiation of reverse transcription of avian and murine retroviral RNAs, using either their natural tRNA primer, tRNATrp and tRNAPro, respectively, or synthetic 18mer oligodeoxyribonucleotides (ODNs) and oligoribonucleotides (ORNs) complementary to their PBS. In both retroviral systems, the initial extension of ODNs was fast and processive. The initial extension of ORNs, tRNATrp and tRNAPro was much slower and distributive, giving rise to the transient accumulation of short pausing products. Synthesis of (-) strong-stop DNA was delayed when using ORNs and tRNAs, compared to ODNs. Even though ORNs and tRNAs were initially extended at the same rate, the short pausing products were more rapidly extended when using the tRNA primers. As a consequence, synthesis of (-) strong-stop DNA was much more efficient with tRNA primers, compared to ORNs. Taken together, these results suggest that the tRNA-primed synthesis of (-) strong-stop DNA is a two-step process, as already observed for HIV-1. The initiation mode corresponds to the initial non-processive nucleotide addition and extension of the short pausing products. It is more efficient with the natural primers than with ORNs. Initiation is followed by a more processive and unspecific elongation mode. Elongation is observed when the primer strand is DNA, i.e. when using the ODNs as primers or when the ORN and tRNA primers have been extended by a sufficient number (depending on the retroviral system) of deoxyribonucleotides.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9016594      PMCID: PMC146480          DOI: 10.1093/nar/25.3.545

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  42 in total

1.  A primer ribonucleic acid for initiation of in vitro Rous sarcarcoma virus deoxyribonucleic acid synthesis.

Authors:  F Harada; R C Sawyer; J E Dahlberg
Journal:  J Biol Chem       Date:  1975-05-10       Impact factor: 5.157

2.  RNA-dependent DNA polymerase in virions of RNA tumour viruses.

Authors:  D Baltimore
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

3.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

Authors:  H M Temin; S Mizutani
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

4.  Restoration of tRNA3Lys-primed(-)-strand DNA synthesis to an HIV-1 reverse transcriptase mutant with extended tRNAs. Implications for retroviral replication.

Authors:  E J Arts; M Ghosh; P S Jacques; B Ehresmann; S F Le Grice
Journal:  J Biol Chem       Date:  1996-04-12       Impact factor: 5.157

5.  Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His).

Authors:  J K Wakefield; S M Kang; C D Morrow
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

Review 6.  tRNAs as primer of reverse transcriptases.

Authors:  R Marquet; C Isel; C Ehresmann; B Ehresmann
Journal:  Biochimie       Date:  1995       Impact factor: 4.079

7.  Initiation of (-) strand DNA synthesis from tRNA(3Lys) on lentiviral RNAs: implications of specific HIV-1 RNA-tRNA(3Lys) interactions inhibiting primer utilization by retroviral reverse transcriptases.

Authors:  E J Arts; S R Stetor; X Li; J W Rausch; K J Howard; B Ehresmann; T W North; B M Wöhrl; R S Goody; M A Wainberg; S F Grice
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

8.  Psoralen crosslinking between human immunodeficiency virus type 1 RNA and primer tRNA3(Lys).

Authors:  E Skripkin; C Isel; R Marquet; B Ehresmann; C Ehresmann
Journal:  Nucleic Acids Res       Date:  1996-02-01       Impact factor: 16.971

9.  Evaluation of human immunodeficiency virus type 1 reverse transcriptase primer tRNA binding by fluorescence spectroscopy: specificity and comparison to primer/template binding.

Authors:  S H Thrall; J Reinstein; B M Wöhrl; R S Goody
Journal:  Biochemistry       Date:  1996-04-09       Impact factor: 3.162

10.  Specific initiation and switch to elongation of human immunodeficiency virus type 1 reverse transcription require the post-transcriptional modifications of primer tRNA3Lys.

Authors:  C Isel; J M Lanchy; S F Le Grice; C Ehresmann; B Ehresmann; R Marquet
Journal:  EMBO J       Date:  1996-02-15       Impact factor: 11.598

View more
  2 in total

1.  Initiation of HIV-2 reverse transcription: a secondary structure model of the RNA-tRNA(Lys3) duplex.

Authors:  F Freund; F Boulmé; S Litvak; L Tarrago-Litvak
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

2.  Initiation of HIV Reverse Transcription.

Authors:  Catherine Isel; Chantal Ehresmann; Roland Marquet
Journal:  Viruses       Date:  2010-01-18       Impact factor: 5.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.